| Natural therapeutics and nutraceuticals for lung diseases: traditional significance, phytochemistry, and pharmacology MM Rahman, S Bibi, MS Rahaman, F Rahman, F Islam, MS Khan, ... Biomedicine & Pharmacotherapy 150, 113041, 2022 | 92 | 2022 |
| Microneedle-based natural polysaccharide for drug delivery systems (DDS): progress and challenges F Damiri, N Kommineni, SO Ebhodaghe, R Bulusu, VGSS Jyothi, ... Pharmaceuticals 15 (2), 190, 2022 | 72 | 2022 |
| MXene (Ti3C2Tx)-Embedded Nanocomposite Hydrogels for Biomedical Applications: A Review F Damiri, MH Rahman, M Zehravi, AA Awaji, MZ Nasrullah, HA Gad, ... Materials 15 (5), 1666, 2022 | 46 | 2022 |
| Serum long noncoding RNAs FAS-AS1 & PVT1 are novel biomarkers for systemic lupus erythematous MA Ali, OG Shaker, AA Khalefa, MY Abdelwahed, EGI Ali, EM Ezzat, ... British Journal of Biomedical Science 77 (4), 208-212, 2020 | 18 | 2020 |
| Study of MDM2 as Prognostic Biomarker in Brain-LGG Cancer and Bioactive Phytochemicals Inhibit the p53-MDM2 Pathway: A Computational Drug Development … P Biswas, S Bibi, Q Yousafi, A Mehmood, S Saleem, A Ihsan, D Dey, ... Molecules 28 (7), 2977, 2023 | 10 | 2023 |
| The diagnostic accuracy of intraoperative frozen section biopsy for diagnosis of sentinel lymph node metastasis in breast cancer patients: a meta-analysis AA Elshanbary, AA Awad, A Abdelsalam, IH Ibrahim, W Abdel-Aziz, ... Environmental Science and Pollution Research 29 (32), 47931-47941, 2022 | 10 | 2022 |
| The influence of rs1859168 polymorphism on serum expression of HOTTIP and its target miR-615-3p in Egyptian patients with breast cancer OO Abdelaleem, OG Shaker, MN AbdelHafez, NK Abdelghaffar, HM Eid, ... Biomolecules 11 (5), 733, 2021 | 10 | 2021 |
| Approaching COVID‐19 with epidemiological genomic surveillance and the sustainability of biodiversity informatics in Africa AT Aborode, H Huang, AA Wireko, A Mehta, J Kalmanovich, ... Journal of Medical Virology 95 (1), e28308, 2023 | 9 | 2023 |
| Development of Novel Class of Phenylpyrazolo[3,4-d]pyrimidine-Based Analogs with Potent Anticancer Activity and Multitarget Enzyme Inhibition Supported by … AKB Aljohani, WAZ El Zaloa, M Alswah, MA Seleem, MM Elsebaei, ... International journal of molecular sciences 24 (19), 15026, 2023 | 2 | 2023 |
| N-and s-substituted Pyrazolopyrimidines: A promising new class of potent c-Src kinase inhibitors with prominent antitumor activity AA Awaji, WAZ El Zaloa, MA Seleem, M Alswah, MM Elsebaei, ... Bioorganic chemistry 145, 107228, 2024 | 1 | 2024 |
| Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies HH Rashwan, AM Taher, HA Hassan, AA Awaji, CJ Kiriacos, RA Assal, ... Pathology-Research and Practice, 155223, 2024 | 1 | 2024 |
| Identification of key molecular pathways and genes in BRCA1 and BRCA2-mutant ovarian cancer: evidence from bioinformatics analysis AA Awaji, AY Maigoro, AT Aborode, AA Akintola, DO Fatoba, EB Idris, ... Genome Instability & Disease, 1-19, 2024 | | 2024 |
| Chemotherapeutic Activity of Imidazolium-Supported Pd(II) o-Vanillylidene Diaminocyclohexane Complexes Immobilized in Nanolipid as Inhibitors for HER2/neu … AA Awaji, MA Rizk, RA Alsaiari, NF Alqahtani, FA Al-Qadri, AS Alkorbi, ... Pharmaceuticals 16 (12), 1711, 2023 | | 2023 |
| Design, Synthesis, In Vitro, and In Silico Studies of New N5-Substituted-pyrazolo[3,4-d]pyrimidinone Derivatives as Anticancer CDK2 Inhibitors WA Zaki, SM El-Sayed, M Alswah, A El-Morsy, AH Bayoumi, AS Mayhoub, ... Pharmaceuticals 16 (11), 1593, 2023 | | 2023 |
| Predictive Identification and Design of Potent Inhibitors Targeting Resistance-Inducing Candidate Genes from E. Coli Whole Genome Sequences AT Aborode, N Kumar, C Olowosoke, TA Ibisanmi, I Ayoade, HI Umar, ... Frontiers in Bioinformatics 4, 1411935, 0 | | |
